Acne Scars
Conditions
Brief summary
This study compares the application of a picosecond 1064-nm laser with a diffractive lens array with nonablative fractional laser for the treatment of acne scarring.
Detailed description
This trial is a 17-week, prospective, randomized split-face study that compares the results between two facial sides either receiving the picosecond 1064-nm laser or nonablative fractional laser treatment for atrophic acne scar.
Interventions
PROCEDURELaser therapy
4 consecutive sessions of laser therapy
Sponsors
Dongtan Sacred Heart Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Split-face comparison study
Eligibility
Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Subjects with facial atrophic acne scars * Subjects who observe the schedules and protocols of the clinical trial * Subjects who give informed consent to participate in the clinical trial
Exclusion criteria
* Subjects who have active acne under treatment * Subjects who had received any other treatments for acne scarring for 6 months prior to the first treatment * Subjects who underwent other treatments including chemical, mechanical or laser resurfacing during the study period * Subjects who have current acute illness * Subjects who are considered inappropriate for the clinical trial under the judgement of investigators
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Changes in the mean of the ECCA grading scale | Week 17 | The ECCA (échelle d'évaluation clinique des cicatrices d'acné) grading scale: minimum score 0; maximum score 270; higher values represent a worse outcome. |
Countries
South Korea
Contacts
PRINCIPAL_INVESTIGATORGyeong-Hun Park, MD, PhD
Dongtan Sacred Heart Hospital, Hallym University College of Medicine
Outcome results
None listed